Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-08

AUTHORS

Russell D. Hull, Sebastian M. Schellong, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G. G. Turpie, Peter Wildgoose, Roger D. Yusen

ABSTRACT

BACKGROUND: Venous thromboembolism (VTE) is a significant cause of mortality and morbidity in medical patients. Although thromboprophylaxis with enoxaparin reduces the risk of VTE in these patients, the optimal duration of therapy is not currently known. The EXCLAIM (EXtended CLinical prophylaxis in Acutely Ill Medical patients) study is designed to compare the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin with the standard regimen of enoxaparin in acutely ill medical patients with recent reduced mobility. METHODS: All enrolled acutely ill medical patients receive enoxaparin 40 mg subcutaneously once daily for 10 +/- 4 days. Eligible patients are then randomized in a blinded manner to receive either extended-duration thromboprophylaxis with enoxaparin 40 mg subcutaneously once daily or placebo subcutaneously once daily for an additional 28 +/- 4 days. The primary efficacy endpoint is the incidence of VTE during the 28 +/- 4 days after randomization. This study utilizes a standardized bilateral compression ultrasonography examination protocol that consists of an intensive interrogation of the deep veins of the lower extremities for proximal deep-vein thrombosis. The secondary efficacy endpoints are the rate of symptomatic VTE during the 3 months after randomization and mortality at 3 and 6 months after enrollment. The primary safety endpoint is the incidence of major hemorrhagic complications during the 28 +/- 4 days after randomization. RESULTS: To date, 3,983 patients, with a broad range of medical conditions, have been included in the study. Almost one third of the enrolled patients with reduced mobility are acutely ill due to respiratory insufficiency and one third have infectious diseases. CONCLUSIONS: The EXCLAIM study is designed to show the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin in acutely ill medical patients with recent reduced mobility, which may potentially lead to a reduction in the incidence of late VTE events in these patients. The EXCLAIM (EXtended CLinical prophylaxis in Acutely Ill Medical patients) study, involving 4,726 acutely ill medical patients with recent reduced mobility, is designed to compare the efficacy and safety of extended-duration thromboprophylaxis using 40 mg once daily enoxaparin (38 +/- 4 days) with the standard regimen for enoxaparin (40 mg once daily for 10 +/- 4 days). The objective of this study is to demonstrate that the extended-duration enoxaparin regimen is an effective and safe thromboprophylaxis regimen out of hospital. More... »

PAGES

31-38

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-006-7732-5

DOI

http://dx.doi.org/10.1007/s11239-006-7732-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034868023

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16786230


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enoxaparin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mobility Limitation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thromboembolism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ultrasonography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Venous Thrombosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Calgary", 
          "id": "https://www.grid.ac/institutes/grid.22072.35", 
          "name": [
            "Thrombosis Research unit, Foothills Hospital, University of Calgary, Room 601 South Tower, 1403 29th Street NW, T2N 2T9, Calgary, Alberta, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hull", 
        "givenName": "Russell D.", 
        "id": "sg:person.012366311137.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012366311137.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Carl Gustav Carus", 
          "id": "https://www.grid.ac/institutes/grid.412282.f", 
          "name": [
            "Universit\u00e4tsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik III, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schellong", 
        "givenName": "Sebastian M.", 
        "id": "sg:person.0615120665.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615120665.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tapson", 
        "givenName": "Victor F.", 
        "id": "sg:person.01161516640.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161516640.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Germans Trias i Pujol", 
          "id": "https://www.grid.ac/institutes/grid.411438.b", 
          "name": [
            "Hospital Germans Trias i Pujol, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Monreal", 
        "givenName": "Manuel", 
        "id": "sg:person.01072473363.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072473363.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Servie d\u2019Hematologie Biologique, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Samama", 
        "givenName": "Meyer-Michel", 
        "id": "sg:person.010641027077.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010641027077.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McMaster University", 
          "id": "https://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "HHSC McMaster Clinic, McMaster University, Hamilton, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Turpie", 
        "givenName": "Alexander G. G.", 
        "id": "sg:person.07661644337.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07661644337.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417555.7", 
          "name": [
            "Sanofi-Aventis, Bridgewater, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wildgoose", 
        "givenName": "Peter", 
        "id": "sg:person.01372476124.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372476124.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Washington University in St. Louis", 
          "id": "https://www.grid.ac/institutes/grid.4367.6", 
          "name": [
            "Washington University School of Medicine, St. Louis, MO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yusen", 
        "givenName": "Roger D.", 
        "id": "sg:person.0603207206.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603207206.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1001/jama.288.3.321", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000900542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000054109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005165257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2003.189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008036605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2003.189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008036605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jcp.50.7.609", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010777238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.164.9.963", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011750271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.1991.00400050081016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012947855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)05249-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018825873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.1994.00420020066008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021070440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa012385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022735357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.160.22.3415", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022872043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000138928.83266.24", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023283093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/014107688908200407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024367047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/014107688908200407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024367047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199909093411103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024754872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.126.3_suppl.338s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027595414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(96)07308-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032398317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000217189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035122401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000196699", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038263172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.302.6778.709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038638909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.162.11.1245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038940435"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(02)07876-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040496634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-4356(00)00373-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042714032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.151.5.933", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054113341"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.154.2.164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054114394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1024/0301-1526.30.4.253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056318624"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-128-8-199804150-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073702184"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-132-9-200005020-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073704101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-134-8-200104170-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073704782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-135-10-200111200-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073704889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-141-10-200411160-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073707441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074810776", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0037-1616243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074859233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0037-1613436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075233218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076615561", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078208552", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083224863", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-08", 
    "datePublishedReg": "2006-08-01", 
    "description": "BACKGROUND: Venous thromboembolism (VTE) is a significant cause of mortality and morbidity in medical patients. Although thromboprophylaxis with enoxaparin reduces the risk of VTE in these patients, the optimal duration of therapy is not currently known. The EXCLAIM (EXtended CLinical prophylaxis in Acutely Ill Medical patients) study is designed to compare the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin with the standard regimen of enoxaparin in acutely ill medical patients with recent reduced mobility.\nMETHODS: All enrolled acutely ill medical patients receive enoxaparin 40 mg subcutaneously once daily for 10 +/- 4 days. Eligible patients are then randomized in a blinded manner to receive either extended-duration thromboprophylaxis with enoxaparin 40 mg subcutaneously once daily or placebo subcutaneously once daily for an additional 28 +/- 4 days. The primary efficacy endpoint is the incidence of VTE during the 28 +/- 4 days after randomization. This study utilizes a standardized bilateral compression ultrasonography examination protocol that consists of an intensive interrogation of the deep veins of the lower extremities for proximal deep-vein thrombosis. The secondary efficacy endpoints are the rate of symptomatic VTE during the 3 months after randomization and mortality at 3 and 6 months after enrollment. The primary safety endpoint is the incidence of major hemorrhagic complications during the 28 +/- 4 days after randomization.\nRESULTS: To date, 3,983 patients, with a broad range of medical conditions, have been included in the study. Almost one third of the enrolled patients with reduced mobility are acutely ill due to respiratory insufficiency and one third have infectious diseases.\nCONCLUSIONS: The EXCLAIM study is designed to show the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin in acutely ill medical patients with recent reduced mobility, which may potentially lead to a reduction in the incidence of late VTE events in these patients. The EXCLAIM (EXtended CLinical prophylaxis in Acutely Ill Medical patients) study, involving 4,726 acutely ill medical patients with recent reduced mobility, is designed to compare the efficacy and safety of extended-duration thromboprophylaxis using 40 mg once daily enoxaparin (38 +/- 4 days) with the standard regimen for enoxaparin (40 mg once daily for 10 +/- 4 days). The objective of this study is to demonstrate that the extended-duration enoxaparin regimen is an effective and safe thromboprophylaxis regimen out of hospital.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-006-7732-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study", 
    "pagination": "31-38", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a6193adc9f1eec665ec97093b71c60754d3f05efee16bdd64e5cf0dc11c06187"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16786230"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-006-7732-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034868023"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-006-7732-5", 
      "https://app.dimensions.ai/details/publication/pub.1034868023"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000523.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-006-7732-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-7732-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-7732-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-7732-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-006-7732-5'


 

This table displays all metadata directly associated to this object as RDF triples.

295 TRIPLES      21 PREDICATES      78 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-006-7732-5 schema:about N13503c6a59644691a4a62aed1bf73155
2 N1aff53dd214c439287e0bc52a51f01ff
3 N1f0e1bf2980849528db90d3432c0e977
4 N28082f809a6c41caabcda294f138a742
5 N42652303dfc646ddbd1d1b92dd1aa99c
6 N42eb40680d074289a174f13c10fd1679
7 Nb165305dfe6c48f7a99399c4d32e8a2a
8 Nc676dbd291714b8eb393f9905754be0f
9 Ncd3522ec13024c378c8c07f41d3e5b13
10 Nd2afdb6094d6429fa8f96d67f87a479a
11 Ndad5a70a69104ce8b65714572485d540
12 Ne67301c6f5bb4185a63b6e5d370c014f
13 Nf307a06b81d9457cac7e4b6e96fd3839
14 Nf525a9cc46ee4ca495ea959d1ec6dfbe
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N2f774aa8c1af49b89951b227a52b4390
18 schema:citation https://app.dimensions.ai/details/publication/pub.1074810776
19 https://app.dimensions.ai/details/publication/pub.1076615561
20 https://app.dimensions.ai/details/publication/pub.1078208552
21 https://app.dimensions.ai/details/publication/pub.1083224863
22 https://doi.org/10.1001/archinte.151.5.933
23 https://doi.org/10.1001/archinte.154.2.164
24 https://doi.org/10.1001/archinte.160.22.3415
25 https://doi.org/10.1001/archinte.162.11.1245
26 https://doi.org/10.1001/archinte.164.9.963
27 https://doi.org/10.1001/archinte.1991.00400050081016
28 https://doi.org/10.1001/archinte.1994.00420020066008
29 https://doi.org/10.1001/jama.288.3.321
30 https://doi.org/10.1016/s0140-6736(00)05249-1
31 https://doi.org/10.1016/s0140-6736(02)07876-5
32 https://doi.org/10.1016/s0140-6736(96)07308-4
33 https://doi.org/10.1016/s0895-4356(00)00373-5
34 https://doi.org/10.1024/0301-1526.30.4.253
35 https://doi.org/10.1055/s-0037-1613436
36 https://doi.org/10.1055/s-0037-1616243
37 https://doi.org/10.1056/nejm199909093411103
38 https://doi.org/10.1056/nejmoa012385
39 https://doi.org/10.1067/mhj.2003.189
40 https://doi.org/10.1136/bmj.302.6778.709
41 https://doi.org/10.1136/jcp.50.7.609
42 https://doi.org/10.1159/000054109
43 https://doi.org/10.1159/000196699
44 https://doi.org/10.1159/000217189
45 https://doi.org/10.1161/01.cir.0000138928.83266.24
46 https://doi.org/10.1177/014107688908200407
47 https://doi.org/10.1378/chest.126.3_suppl.338s
48 https://doi.org/10.7326/0003-4819-128-8-199804150-00011
49 https://doi.org/10.7326/0003-4819-132-9-200005020-00002
50 https://doi.org/10.7326/0003-4819-134-8-200104170-00011
51 https://doi.org/10.7326/0003-4819-135-10-200111200-00006
52 https://doi.org/10.7326/0003-4819-141-10-200411160-00009
53 schema:datePublished 2006-08
54 schema:datePublishedReg 2006-08-01
55 schema:description BACKGROUND: Venous thromboembolism (VTE) is a significant cause of mortality and morbidity in medical patients. Although thromboprophylaxis with enoxaparin reduces the risk of VTE in these patients, the optimal duration of therapy is not currently known. The EXCLAIM (EXtended CLinical prophylaxis in Acutely Ill Medical patients) study is designed to compare the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin with the standard regimen of enoxaparin in acutely ill medical patients with recent reduced mobility. METHODS: All enrolled acutely ill medical patients receive enoxaparin 40 mg subcutaneously once daily for 10 +/- 4 days. Eligible patients are then randomized in a blinded manner to receive either extended-duration thromboprophylaxis with enoxaparin 40 mg subcutaneously once daily or placebo subcutaneously once daily for an additional 28 +/- 4 days. The primary efficacy endpoint is the incidence of VTE during the 28 +/- 4 days after randomization. This study utilizes a standardized bilateral compression ultrasonography examination protocol that consists of an intensive interrogation of the deep veins of the lower extremities for proximal deep-vein thrombosis. The secondary efficacy endpoints are the rate of symptomatic VTE during the 3 months after randomization and mortality at 3 and 6 months after enrollment. The primary safety endpoint is the incidence of major hemorrhagic complications during the 28 +/- 4 days after randomization. RESULTS: To date, 3,983 patients, with a broad range of medical conditions, have been included in the study. Almost one third of the enrolled patients with reduced mobility are acutely ill due to respiratory insufficiency and one third have infectious diseases. CONCLUSIONS: The EXCLAIM study is designed to show the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin in acutely ill medical patients with recent reduced mobility, which may potentially lead to a reduction in the incidence of late VTE events in these patients. The EXCLAIM (EXtended CLinical prophylaxis in Acutely Ill Medical patients) study, involving 4,726 acutely ill medical patients with recent reduced mobility, is designed to compare the efficacy and safety of extended-duration thromboprophylaxis using 40 mg once daily enoxaparin (38 +/- 4 days) with the standard regimen for enoxaparin (40 mg once daily for 10 +/- 4 days). The objective of this study is to demonstrate that the extended-duration enoxaparin regimen is an effective and safe thromboprophylaxis regimen out of hospital.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree false
59 schema:isPartOf N4b0c6bcb99ca4e1e8f6aff9a060e2eed
60 Nb244f0606ef2438bbc5a6115e3c0e756
61 sg:journal.1113719
62 schema:name Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study
63 schema:pagination 31-38
64 schema:productId N3db9dbaee0874494810a899c153e93cf
65 N3fd147c477264d88bef456a1eb16df86
66 N6ee6b0d3121a49bcbe75cd560ae90529
67 Nccf8cd39b91c46b3b91218bd0a96bf1f
68 Ncf24bd7f5b5d490ca78ce3e52bfb4c74
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034868023
70 https://doi.org/10.1007/s11239-006-7732-5
71 schema:sdDatePublished 2019-04-10T21:39
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher Na89ba5bdf6574d4f9c626253cbbece3c
74 schema:url http://link.springer.com/10.1007%2Fs11239-006-7732-5
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N13503c6a59644691a4a62aed1bf73155 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Enoxaparin
80 rdf:type schema:DefinedTerm
81 N1aff53dd214c439287e0bc52a51f01ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Humans
83 rdf:type schema:DefinedTerm
84 N1c35cdeac2d24dd5a59af30fa0ac204c rdf:first sg:person.01161516640.65
85 rdf:rest Nc50bac40b4e54d558c2b2ca6f7d2863b
86 N1f0e1bf2980849528db90d3432c0e977 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Aged, 80 and over
88 rdf:type schema:DefinedTerm
89 N28082f809a6c41caabcda294f138a742 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Adult
91 rdf:type schema:DefinedTerm
92 N28880038ee2642f9b75d4f89af379644 schema:name Servie d’Hematologie Biologique, Paris, France
93 rdf:type schema:Organization
94 N2f774aa8c1af49b89951b227a52b4390 rdf:first sg:person.012366311137.39
95 rdf:rest N764fbd6344d3441fb462b8751f39cb1c
96 N34f5cc4a73fa434e96f42daa51234b4d rdf:first sg:person.0603207206.70
97 rdf:rest rdf:nil
98 N3db9dbaee0874494810a899c153e93cf schema:name readcube_id
99 schema:value a6193adc9f1eec665ec97093b71c60754d3f05efee16bdd64e5cf0dc11c06187
100 rdf:type schema:PropertyValue
101 N3fd147c477264d88bef456a1eb16df86 schema:name nlm_unique_id
102 schema:value 9502018
103 rdf:type schema:PropertyValue
104 N42652303dfc646ddbd1d1b92dd1aa99c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Middle Aged
106 rdf:type schema:DefinedTerm
107 N42eb40680d074289a174f13c10fd1679 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Mobility Limitation
109 rdf:type schema:DefinedTerm
110 N4b0c6bcb99ca4e1e8f6aff9a060e2eed schema:volumeNumber 22
111 rdf:type schema:PublicationVolume
112 N55cf6354227a4600bd94b480c86bff22 rdf:first sg:person.01372476124.58
113 rdf:rest N34f5cc4a73fa434e96f42daa51234b4d
114 N6ee6b0d3121a49bcbe75cd560ae90529 schema:name pubmed_id
115 schema:value 16786230
116 rdf:type schema:PropertyValue
117 N764fbd6344d3441fb462b8751f39cb1c rdf:first sg:person.0615120665.18
118 rdf:rest N1c35cdeac2d24dd5a59af30fa0ac204c
119 N91ea15b4304743dbaf0ba8bf9adea32a rdf:first sg:person.07661644337.25
120 rdf:rest N55cf6354227a4600bd94b480c86bff22
121 Na89ba5bdf6574d4f9c626253cbbece3c schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 Nb165305dfe6c48f7a99399c4d32e8a2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Ultrasonography
125 rdf:type schema:DefinedTerm
126 Nb244f0606ef2438bbc5a6115e3c0e756 schema:issueNumber 1
127 rdf:type schema:PublicationIssue
128 Nc50bac40b4e54d558c2b2ca6f7d2863b rdf:first sg:person.01072473363.80
129 rdf:rest Ncda2d64b09ff4901af3b6bc9ec8fa6aa
130 Nc676dbd291714b8eb393f9905754be0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Thromboembolism
132 rdf:type schema:DefinedTerm
133 Nccf8cd39b91c46b3b91218bd0a96bf1f schema:name dimensions_id
134 schema:value pub.1034868023
135 rdf:type schema:PropertyValue
136 Ncd3522ec13024c378c8c07f41d3e5b13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged
138 rdf:type schema:DefinedTerm
139 Ncda2d64b09ff4901af3b6bc9ec8fa6aa rdf:first sg:person.010641027077.79
140 rdf:rest N91ea15b4304743dbaf0ba8bf9adea32a
141 Ncf24bd7f5b5d490ca78ce3e52bfb4c74 schema:name doi
142 schema:value 10.1007/s11239-006-7732-5
143 rdf:type schema:PropertyValue
144 Nd2afdb6094d6429fa8f96d67f87a479a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Female
146 rdf:type schema:DefinedTerm
147 Ndad5a70a69104ce8b65714572485d540 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Male
149 rdf:type schema:DefinedTerm
150 Ne67301c6f5bb4185a63b6e5d370c014f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Venous Thrombosis
152 rdf:type schema:DefinedTerm
153 Nf307a06b81d9457cac7e4b6e96fd3839 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Double-Blind Method
155 rdf:type schema:DefinedTerm
156 Nf525a9cc46ee4ca495ea959d1ec6dfbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Anticoagulants
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
163 schema:name Clinical Sciences
164 rdf:type schema:DefinedTerm
165 sg:journal.1113719 schema:issn 0929-5305
166 1573-742X
167 schema:name Journal of Thrombosis and Thrombolysis
168 rdf:type schema:Periodical
169 sg:person.010641027077.79 schema:affiliation N28880038ee2642f9b75d4f89af379644
170 schema:familyName Samama
171 schema:givenName Meyer-Michel
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010641027077.79
173 rdf:type schema:Person
174 sg:person.01072473363.80 schema:affiliation https://www.grid.ac/institutes/grid.411438.b
175 schema:familyName Monreal
176 schema:givenName Manuel
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072473363.80
178 rdf:type schema:Person
179 sg:person.01161516640.65 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
180 schema:familyName Tapson
181 schema:givenName Victor F.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161516640.65
183 rdf:type schema:Person
184 sg:person.012366311137.39 schema:affiliation https://www.grid.ac/institutes/grid.22072.35
185 schema:familyName Hull
186 schema:givenName Russell D.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012366311137.39
188 rdf:type schema:Person
189 sg:person.01372476124.58 schema:affiliation https://www.grid.ac/institutes/grid.417555.7
190 schema:familyName Wildgoose
191 schema:givenName Peter
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372476124.58
193 rdf:type schema:Person
194 sg:person.0603207206.70 schema:affiliation https://www.grid.ac/institutes/grid.4367.6
195 schema:familyName Yusen
196 schema:givenName Roger D.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603207206.70
198 rdf:type schema:Person
199 sg:person.0615120665.18 schema:affiliation https://www.grid.ac/institutes/grid.412282.f
200 schema:familyName Schellong
201 schema:givenName Sebastian M.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615120665.18
203 rdf:type schema:Person
204 sg:person.07661644337.25 schema:affiliation https://www.grid.ac/institutes/grid.25073.33
205 schema:familyName Turpie
206 schema:givenName Alexander G. G.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07661644337.25
208 rdf:type schema:Person
209 https://app.dimensions.ai/details/publication/pub.1074810776 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1076615561 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1078208552 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1083224863 schema:CreativeWork
213 https://doi.org/10.1001/archinte.151.5.933 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054113341
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1001/archinte.154.2.164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054114394
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1001/archinte.160.22.3415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022872043
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1001/archinte.162.11.1245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038940435
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1001/archinte.164.9.963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011750271
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1001/archinte.1991.00400050081016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012947855
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1001/archinte.1994.00420020066008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021070440
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1001/jama.288.3.321 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000900542
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/s0140-6736(00)05249-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018825873
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/s0140-6736(02)07876-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040496634
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/s0140-6736(96)07308-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032398317
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/s0895-4356(00)00373-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042714032
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1024/0301-1526.30.4.253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056318624
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1055/s-0037-1613436 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075233218
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1055/s-0037-1616243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074859233
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1056/nejm199909093411103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024754872
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1056/nejmoa012385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022735357
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1067/mhj.2003.189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008036605
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1136/bmj.302.6778.709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038638909
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1136/jcp.50.7.609 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010777238
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1159/000054109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005165257
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1159/000196699 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038263172
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1159/000217189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035122401
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1161/01.cir.0000138928.83266.24 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023283093
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1177/014107688908200407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024367047
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1378/chest.126.3_suppl.338s schema:sameAs https://app.dimensions.ai/details/publication/pub.1027595414
264 rdf:type schema:CreativeWork
265 https://doi.org/10.7326/0003-4819-128-8-199804150-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073702184
266 rdf:type schema:CreativeWork
267 https://doi.org/10.7326/0003-4819-132-9-200005020-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073704101
268 rdf:type schema:CreativeWork
269 https://doi.org/10.7326/0003-4819-134-8-200104170-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073704782
270 rdf:type schema:CreativeWork
271 https://doi.org/10.7326/0003-4819-135-10-200111200-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073704889
272 rdf:type schema:CreativeWork
273 https://doi.org/10.7326/0003-4819-141-10-200411160-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073707441
274 rdf:type schema:CreativeWork
275 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
276 schema:name Duke University Medical Center, Durham, NC, USA
277 rdf:type schema:Organization
278 https://www.grid.ac/institutes/grid.22072.35 schema:alternateName University of Calgary
279 schema:name Thrombosis Research unit, Foothills Hospital, University of Calgary, Room 601 South Tower, 1403 29th Street NW, T2N 2T9, Calgary, Alberta, Canada
280 rdf:type schema:Organization
281 https://www.grid.ac/institutes/grid.25073.33 schema:alternateName McMaster University
282 schema:name HHSC McMaster Clinic, McMaster University, Hamilton, Ontario, Canada
283 rdf:type schema:Organization
284 https://www.grid.ac/institutes/grid.411438.b schema:alternateName Hospital Universitari Germans Trias i Pujol
285 schema:name Hospital Germans Trias i Pujol, Barcelona, Spain
286 rdf:type schema:Organization
287 https://www.grid.ac/institutes/grid.412282.f schema:alternateName University Hospital Carl Gustav Carus
288 schema:name Universitätsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik III, Dresden, Germany
289 rdf:type schema:Organization
290 https://www.grid.ac/institutes/grid.417555.7 schema:alternateName Sanofi (United States)
291 schema:name Sanofi-Aventis, Bridgewater, NJ, USA
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.4367.6 schema:alternateName Washington University in St. Louis
294 schema:name Washington University School of Medicine, St. Louis, MO, USA
295 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...